ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2026
Idag, 10:00
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2026
Zinzino group revenue increased with a total of 15 %, compared with the previous year.
The revenue in August for Zinzino's sales markets increased by 16 % and amounted to SEK 280.9 (242.5) million. Faun Pharma's external sales amounted to SEK 1.3 (3.4) million. Overall, the Group increased revenues by 15 % to SEK 282.2 (245.9) million compared with the previous year.
Accumulated revenue for January – August 2026 increased by 22 % to SEK 2,464.8 (2,027.8) million.
Revenues were distributed as follows:
Regions,MSEK | 26-Aug | 25-Aug | Change | YTD 2026 | YTD 2025 | Change |
The Nordics | 23.6 | 27.0 | -13% | 206.8 | 208.7 | -1% |
Central Europe | 85.3 | 72.3 | 18% | 742.6 | 564.1 | 32% |
East Europe | 23.8 | 28.8 | -17% | 217.5 | 246.8 | -12% |
South & West Europe | 44.2 | 39.9 | 11% | 402.1 | 349.1 | 15% |
The Baltics | 7.6 | 9.7 | -22% | 73.0 | 76.4 | -4% |
North America | 63.0 | 39.2 | 61% | 531.8 | 333.9 | 59% |
South America | 2.5 | 1.4 | 79% | 29.2 | 6.9 | 323% |
Asia-Pacific | 28.8 | 22.1 | 30% | 206.0 | 191.2 | 8% |
Africa | 2.1 | 2.1 | 0% | 16.7 | 14.1 | 18% |
Zinzino | 280.9 | 242.5 | 16% | 2,425.7 | 1,991.2 | 22% |
Faun Pharma | 1.3 | 3.4 | -62% | 39.1 | 36.6 | 7% |
Zinzino Group | 282.2 | 245.9 | 15% | 2,464.8 | 2,027.8 | 22% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Tapper Partners AB
Zinzinois a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.
Ämnen i artikeln
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2026
Idag, 10:00
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2026
Zinzino group revenue increased with a total of 15 %, compared with the previous year.
The revenue in August for Zinzino's sales markets increased by 16 % and amounted to SEK 280.9 (242.5) million. Faun Pharma's external sales amounted to SEK 1.3 (3.4) million. Overall, the Group increased revenues by 15 % to SEK 282.2 (245.9) million compared with the previous year.
Accumulated revenue for January – August 2026 increased by 22 % to SEK 2,464.8 (2,027.8) million.
Revenues were distributed as follows:
Regions,MSEK | 26-Aug | 25-Aug | Change | YTD 2026 | YTD 2025 | Change |
The Nordics | 23.6 | 27.0 | -13% | 206.8 | 208.7 | -1% |
Central Europe | 85.3 | 72.3 | 18% | 742.6 | 564.1 | 32% |
East Europe | 23.8 | 28.8 | -17% | 217.5 | 246.8 | -12% |
South & West Europe | 44.2 | 39.9 | 11% | 402.1 | 349.1 | 15% |
The Baltics | 7.6 | 9.7 | -22% | 73.0 | 76.4 | -4% |
North America | 63.0 | 39.2 | 61% | 531.8 | 333.9 | 59% |
South America | 2.5 | 1.4 | 79% | 29.2 | 6.9 | 323% |
Asia-Pacific | 28.8 | 22.1 | 30% | 206.0 | 191.2 | 8% |
Africa | 2.1 | 2.1 | 0% | 16.7 | 14.1 | 18% |
Zinzino | 280.9 | 242.5 | 16% | 2,425.7 | 1,991.2 | 22% |
Faun Pharma | 1.3 | 3.4 | -62% | 39.1 | 36.6 | 7% |
Zinzino Group | 282.2 | 245.9 | 15% | 2,464.8 | 2,027.8 | 22% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Tapper Partners AB
Zinzinois a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.
Ämnen i artikeln
Privatekonomi
Analys
Privatekonomi
Analys
Marknadsöversikt
1 DAG %
Senast
1 mån
